.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Asgeir Store Jakola

Göteborg / SE

Speaker

Tu, 11/06/2024
16:30 – 16:45 15 Min. 0 Min.
Plenarvortrag | Plenary lecture
Surgery for low-grade gliomas – Do different tumor subtypes need different strategies?

Further involvements

Mo, 10/06/2024
14:40 – 14:50 7 Min. 3 Min.
Abstractvortrag | Abstract talk
V057
Die T1/T2-Tumorvolumen-Ratio ist bei Patientinnen und Patienten mit IDH.mutierten, ZNS WHO Grad 2 und 3 Astrozytomen mit dem Resektionsausmaß assoziiert
The ratio of T1 to T2 tumor volume (T1/T2 ratio) is associated with resectability in patients with IDH-mutant astrocytomas CNS WHO grades 2 and 3
Tumor